Overly broad definitions, a lack of appropriate, or any, comparison groups, among other things, in studies looking at the incidence, prevalence, and control of the condition-;epidemiology-;have distorted the risks, say the researchers.
Sandoz disavows U.K. trade group over dispute about promoting a biosimilar for multiple sclerosis
In an unusual move, Sandoz is no longer cooperating with a U.K. industry trade group following a dispute over allegations that the company inappropriately marketed
May 13, 2024